Glipizide
- Product NDC
- 53002-2111
- 11-digit product format
- 530022111
- Labeler code
- 53002
- Product ID
- 53002-2111_eeb762f9-917d-4697-b650-1371ada361e8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glipizide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA075795
- Marketing category
- ANDA
- Marketing start
- 2002-09-25
- Marketing end
- 0000-00-00
- Substance
- GLIPIZIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Sulfonylurea [EPC],Sulfonylurea Compounds [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 53002-2111-0 | 2025-01-30 | C162847 | 48780-1 | 9d75b9cf-e147-f424-e053-dadaa90a57ce | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 53002-2111-3 | 2025-01-30 | C162847 | 48780-1 | 9d75b9cf-e147-f424-e053-dadaa90a57ce | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 53002-2111-6 | 2025-01-30 | C162847 | 48780-1 | 9d75b9cf-e147-f424-e053-dadaa90a57ce | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 53002-2111-0 | 2023-06-07 | C162847 | 48780-1 | 9d75b9cf-e147-f424-e053-dadaa90a57ce | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 53002-2111-3 | 2023-06-07 | C162847 | 48780-1 | 9d75b9cf-e147-f424-e053-dadaa90a57ce | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 53002-2111-6 | 2023-06-07 | C162847 | 48780-1 | 9d75b9cf-e147-f424-e053-dadaa90a57ce | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 53002-2111-0 | 2020-12-17 | C162847 | 48780-1 | 9d75b9cf-e147-f424-e053-dadaa90a57ce | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 53002-2111-3 | 2020-12-17 | C162847 | 48780-1 | 9d75b9cf-e147-f424-e053-dadaa90a57ce | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 53002-2111-6 | 2020-12-17 | C162847 | 48780-1 | 9d75b9cf-e147-f424-e053-dadaa90a57ce | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 53002-2111-0 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-e147-f424-e053-dadaa90a57ce | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 53002-2111-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-e147-f424-e053-dadaa90a57ce | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
| 53002-2111-6 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-e147-f424-e053-dadaa90a57ce | GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53002-2111-0 | Glipizide | 100 in 1 BOTTLE | TABLET | 100 | | 8 |
| 53002-2111-3 | Glipizide | 30 in 1 BOTTLE | TABLET | 30 | | 8 |
| 53002-2111-6 | Glipizide | 60 in 1 BOTTLE | TABLET | 60 | | 8 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53002-2111 | GLIPIZIDE TABLET [RPK PHARMACEUTICALS, INC.] | 8 | Legacy NDC, 3 package rows | 20230609_fdccb7bd-6eb5-4bc2-b4f5-b49608df479f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53002-2111-0 | 53002211100 | 100 TABLET in 1 BOTTLE (53002-2111-0) | 100 tablet | 2018-10-01 | 0000-00-00 | No | No | Current |
| 53002-2111-3 | 53002211103 | 30 TABLET in 1 BOTTLE (53002-2111-3) | 30 tablet | 2018-10-01 | 0000-00-00 | No | No | Current |
| 53002-2111-6 | 53002211106 | 60 TABLET in 1 BOTTLE (53002-2111-6) | 60 tablet | 2018-10-01 | 0000-00-00 | No | No | Current |